AMELIVIE Trademark

Trademark Overview

On Friday, February 3, 2017, a trademark application was filed for AMELIVIE with the United States Patent and Trademark Office. The USPTO has given the AMELIVIE trademark a serial number of 87323546. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, July 27, 2020. This trademark is owned by AbbVie Inc.. The AMELIVIE trademark is filed in the Pharmaceutical Products category with the following description:

pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders
amelivie

General Information

Serial Number87323546
Word MarkAMELIVIE
Filing DateFriday, February 3, 2017
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, July 27, 2020
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 25, 2017

Trademark Statements

Goods and Servicespharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, February 8, 2017
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameAbbVie Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressNorth Chicago, IL 60064
Party NameAbbVie Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNorth Chicago, IL 60064

Trademark Events

Event DateEvent Description
Monday, July 27, 2020ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, July 27, 2020ABANDONMENT - NO USE STATEMENT FILED
Wednesday, December 4, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, December 3, 2019EXTENSION 5 GRANTED
Wednesday, November 27, 2019EXTENSION 5 FILED
Tuesday, December 3, 2019CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, November 27, 2019TEAS EXTENSION RECEIVED
Wednesday, June 19, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, June 17, 2019EXTENSION 4 GRANTED
Monday, June 17, 2019EXTENSION 4 FILED
Monday, June 17, 2019TEAS EXTENSION RECEIVED
Saturday, December 15, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, December 13, 2018EXTENSION 3 GRANTED
Thursday, December 13, 2018EXTENSION 3 FILED
Thursday, December 13, 2018TEAS EXTENSION RECEIVED
Wednesday, June 13, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, June 11, 2018EXTENSION 2 GRANTED
Monday, June 11, 2018EXTENSION 2 FILED
Monday, June 11, 2018TEAS EXTENSION RECEIVED
Friday, December 15, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, December 13, 2017EXTENSION 1 GRANTED
Wednesday, December 13, 2017EXTENSION 1 FILED
Wednesday, December 13, 2017TEAS EXTENSION RECEIVED
Wednesday, June 21, 2017NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, April 25, 2017OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, April 25, 2017PUBLISHED FOR OPPOSITION
Wednesday, April 5, 2017NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Friday, March 10, 2017APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, March 10, 2017ASSIGNED TO EXAMINER
Wednesday, February 8, 2017NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Tuesday, February 7, 2017NEW APPLICATION ENTERED IN TRAM

Related Keywords

amelivie gastrointestinal hormonal neurological respiratory ophthalmic dermatological psychiatric diseases disorders related